MAP7D2 is a microtubule-associated protein of the MAP7/ensconsin family that localizes to the proximal axon and serves as a critical cofactor for kinesin-1-mediated cargo transport. The protein directly binds microtubules via its N-terminal region and interacts with kinesin-1 family members (KIF5A/B/C) through its C-terminus. MAP7D2 functions to recruit and activate kinesin-1 on microtubules at the proximal axon/axon initial segment, thereby gating anterograde transport of organelles (mitochondria, lysosomes, ER-derived vesicles) into the axon. It stabilizes microtubules through direct binding and plays roles in controlling cell motility and neurite outgrowth. The protein also localizes to centrosomes, midbody during cytokinesis, and neuron projections. Recent GWAS studies have implicated MAP7D2 in age-related hearing loss, consistent with its expression in inner ear hair cells.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0000226
microtubule cytoskeleton organization
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation based on phylogenetic inference from MAP7 family members. MAP7D2 belongs to the MAP7 family which includes MAP7, MAP7D1, MAP7D2, and MAP7D3, all of which regulate microtubule organization. Pan et al. 2019 demonstrated that MAP7D2 localizes to microtubules and regulates their organization at the proximal axon. Kikuchi et al. 2022 showed MAP7D2 stabilizes microtubules through direct binding [file:human/MAP7D2/MAP7D2-deep-research-falcon.md].
Reason: This annotation is well-supported by both phylogenetic evidence and direct experimental studies. MAP7D2 clearly functions in microtubule cytoskeleton organization as a core function, recruiting kinesin-1 to microtubules and stabilizing them.
Supporting Evidence:
PMID:30784582
MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-Mediated Cargo Transport into the Axon
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2 and MAP7D1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells
|
|
GO:0015630
microtubule cytoskeleton
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for cellular component. MAP7D2 is active in the microtubule cytoskeleton, binding directly to microtubules and recruiting kinesin-1 motor proteins. This is the primary site of MAP7D2 function.
Reason: This cellular component annotation accurately reflects where MAP7D2 functions. The protein binds microtubules via its N-terminal domain and this is its primary site of activity.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2's N-terminus binds microtubules; its C-terminus underlies kinesin-1 interaction
|
|
GO:0000226
microtubule cytoskeleton organization
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation from combined automated methods, consistent with ortholog annotations and InterPro domain predictions. This duplicates the IBA annotation with different evidence.
Reason: While this duplicates the IBA annotation, the IEA annotation correctly captures the same function from automated pipelines. The annotation is accurate.
Supporting Evidence:
PMID:30784582
MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-Mediated Cargo Transport into the Axon
|
|
GO:0005813
centrosome
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation based on ortholog data. Kikuchi et al. 2022 showed that MAP7D2 is prominent at centrosomes in neuronal cell lines. UniProt also notes centrosomal localization based on similarity evidence.
Reason: Centrosome localization is supported by experimental data from mouse orthologs and is consistent with MAP7D2's role as a microtubule-associated protein.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2 is prominent at centrosomes and partially along microtubules
|
|
GO:0005856
cytoskeleton
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: IEA annotation from UniProtKB subcellular location mapping. This is a broader term than GO:0015630 (microtubule cytoskeleton).
Reason: While this is a more general term than the microtubule cytoskeleton annotation, it is not incorrect. MAP7D2 is indeed a cytoskeleton-associated protein. The more specific microtubule cytoskeleton annotation provides better granularity.
Supporting Evidence:
UniProt:Q96T17
Cytoplasm, cytoskeleton
|
|
GO:0015630
microtubule cytoskeleton
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation from combined automated methods, duplicating the IBA annotation. Well-supported by ortholog data.
Reason: Accurate annotation consistent with the IBA evidence. MAP7D2 functions at the microtubule cytoskeleton.
Supporting Evidence:
PMID:30784582
MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-Mediated Cargo Transport into the Axon
|
|
GO:0030424
axon
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation based on ortholog data. This is strongly supported by experimental evidence. Pan et al. 2019 demonstrated that MAP7D2 accumulates at the proximal axon in hippocampal neurons, and this localization is critical for its function in gating kinesin-1-mediated transport.
Reason: Axon localization is a core aspect of MAP7D2 function and is directly supported by published experimental evidence from PMID:30784582 (Pan et al. 2019).
Supporting Evidence:
PMID:30784582
MAP7D2-N) accumulates at the proximal axon
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2 localizes to the proximal axon and locally promotes kinesin-1-mediated cargo transport into the axon
|
|
GO:0030496
midbody
|
IEA
GO_REF:0000120 |
KEEP AS NON CORE |
Summary: IEA annotation based on ortholog data. Kikuchi et al. 2022 showed MAP7D2 accumulates at the midbody during cytokinesis. UniProt confirms this localization by similarity.
Reason: Midbody localization during cytokinesis is a secondary aspect of MAP7D2 function, not its core role in axonal transport. The annotation is accurate but represents a non-core function.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
accumulates at the midbody during cytokinesis
|
|
GO:0043005
neuron projection
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation based on ortholog data. MAP7D2 localizes to neuron projections, particularly the axon. This is consistent with its primary role in neurons.
Reason: Neuron projection localization is accurate and represents a core aspect of MAP7D2 function in neuronal cells.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2 concentrates at the proximal axon (overlapping the AIS region) in developing hippocampal neurons
|
|
GO:0005874
microtubule
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara ortholog transfer. MAP7D2 directly binds microtubules via its N-terminal domain. Kikuchi et al. 2022 determined binding affinity (KD ~6x10^-7 M).
Reason: Microtubule localization is fundamental to MAP7D2 function. The protein directly binds microtubules as demonstrated biochemically.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
Microtubule co-sedimentation determined an apparent KD on the order of ~6x10^-7 M
|
|
GO:0008017
microtubule binding
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation from combined automated methods. Microtubule binding is a core molecular function of MAP7D2, mediated by the N-terminal region.
Reason: This is a core molecular function of MAP7D2. The protein binds microtubules directly and this binding is essential for its function in kinesin-1 recruitment.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2 directly binds microtubules via its N-terminal half
|
|
GO:0019894
kinesin binding
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation from combined automated methods. MAP7D2 interacts with kinesin-1 family members (KIF5A, KIF5B, KIF5C) through its C-terminal domain. This interaction is critical for promoting kinesin-1-mediated axonal transport.
Reason: Kinesin binding is a core molecular function of MAP7D2. The protein serves as a cofactor that recruits and activates kinesin-1 on microtubules.
Supporting Evidence:
PMID:30784582
Kinesin-1-Mediated Cargo Transport into the Axon
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7 family proteins regulate kinesin-1 recruitment and activation
|
|
GO:0061564
axon development
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. MAP7D2 contributes to axon development by facilitating polarized entry of cargoes into axons, supporting axon formation and branching.
Reason: Axon development is a core biological process for MAP7D2. The protein's role in kinesin-1-mediated cargo transport at the proximal axon directly contributes to axon development and neuronal polarity.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2 facilitates polarized entry of cargoes (mitochondria, lysosomes, ER-derived organelles) into axons, thereby contributing to axon formation, branching, and neuronal migration
|
|
GO:0140778
microtubule stabilizing activity
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation from Ensembl Compara. MAP7D2 stabilizes microtubules through direct binding. Kikuchi et al. 2022 showed that MAP7D2 loss reduces nocodazole resistance (indicating reduced MT stability).
Reason: Microtubule stabilizing activity is a core molecular function of MAP7D2. This has been directly demonstrated experimentally.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2 directly binds microtubules via its N-terminal half and stabilizes microtubules
|
|
GO:0000226
microtubule cytoskeleton organization
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation based on sequence similarity to rat ortholog (D4A4L4). This duplicates the IBA annotation with different evidence type.
Reason: The annotation accurately captures MAP7D2's role in microtubule cytoskeleton organization. ISS evidence from well-characterized orthologs is reliable.
Supporting Evidence:
PMID:30784582
MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-Mediated Cargo Transport into the Axon
|
|
GO:0008017
microtubule binding
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation based on sequence similarity. Duplicates the IEA annotation. Microtubule binding is well-established for MAP7D2.
Reason: Core molecular function accurately captured. The ISS evidence provides additional confidence from ortholog studies.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2's N-terminus binds microtubules
|
|
GO:0019894
kinesin binding
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation based on sequence similarity. Duplicates the IEA annotation. Kinesin binding is a core function of MAP7D2.
Reason: Core molecular function. MAP7D2 binding to kinesin-1 family members is essential for its biological role.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2 interacts with kinesin-1 family members (KIF5A/B/C)
|
|
GO:0061564
axon development
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation based on sequence similarity. Duplicates the IEA annotation. Axon development is a core process for MAP7D2.
Reason: Core biological process. MAP7D2's role in axon development through kinesin-1 recruitment is well-documented.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
contributing to axon formation, branching, and neuronal migration
|
|
GO:0005813
centrosome
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation based on sequence similarity to mouse ortholog (A2AG50). Duplicates the IEA annotation. Centrosome localization is documented.
Reason: Accurate cellular localization supported by ortholog studies. Centrosome localization is consistent with MAP7D2's role in microtubule organization.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2 is prominent at centrosomes
|
|
GO:0005874
microtubule
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation based on sequence similarity. Duplicates the IEA annotation. MAP7D2 localizes to microtubules via direct binding.
Reason: Core cellular localization. MAP7D2 directly binds and localizes to microtubules.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2 directly binds microtubules via its N-terminal half
|
|
GO:0030496
midbody
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation based on sequence similarity. Duplicates the IEA annotation. Midbody localization during cytokinesis is documented.
Reason: Accurate localization but represents a non-core function. Midbody accumulation during cytokinesis is secondary to MAP7D2's primary role in axonal transport.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
accumulates at the midbody during cytokinesis
|
|
GO:0043005
neuron projection
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation based on sequence similarity. Duplicates the IEA annotation. MAP7D2 localizes to neuron projections, especially axons.
Reason: Core cellular localization for MAP7D2's function in neurons.
Supporting Evidence:
file:human/MAP7D2/MAP7D2-deep-research-falcon.md
MAP7D2 concentrates at the proximal axon (overlapping the AIS region) in developing hippocampal neurons
|
Q: Does MAP7D2 have specific roles in inner ear hair cells beyond general kinesin-1 recruitment, given the GWAS association with hearing loss?
Q: What is the relationship between MAP7D2 and other MAP7 family members in regulating axonal transport - are they redundant or do they have distinct cargo specificities?
Q: Does MAP7D2 play a role in non-neuronal cell types, given its expression in brain and epididymis?
Experiment: Conditional knockout of MAP7D2 in mouse inner ear to validate hearing loss phenotype
Hypothesis: Loss of MAP7D2 in inner ear cells leads to hearing impairment due to disrupted intracellular transport
Experiment: Live imaging of cargo transport in neurons with MAP7D2 depletion to determine cargo specificity
Hypothesis: MAP7D2 has cargo-specific roles in axonal transport distinct from other MAP7 family members
Experiment: Structure determination of MAP7D2-microtubule and MAP7D2-kinesin-1 complexes to understand molecular mechanism
Hypothesis: MAP7D2 binds simultaneously to microtubules and kinesin-1 to facilitate motor protein recruitment
MAP7D2 (MAP7 domain-containing protein 2) is a microtubule-associated protein encoded by the MAP7D2 gene located on chromosome Xp22.12 in humans (UniProt: Q96T17). The protein belongs to the MAP7 family, which in mammals comprises four members: MAP7 (also known as ensconsin or E-MAP-115), MAP7D1, MAP7D2, and MAP7D3 [hooikaas-2019-map7-kinesin-abstract]. Unlike traditional microtubule-associated proteins such as tau or MAP2, the MAP7 family members are distinguished by their unique ability to interact with both microtubules and the motor protein kinesin-1, functioning as essential cofactors for kinesin-1-driven intracellular transport [hooikaas-2019-map7-kinesin-summary].
MAP7D2 serves a dual function: it directly stabilizes microtubules through physical binding, and it acts as a critical cofactor for kinesin-1-mediated cargo transport [kikuchi-2022-map7d2-stabilization-abstract]. The protein is predominantly expressed in the brain and testis, with particularly high expression in the glomerular layer of the olfactory bulb and Sertoli cells [kikuchi-2022-map7d2-stabilization-summary]. In neurons, MAP7D2 exhibits a distinctive subcellular localization pattern, concentrating at the proximal axon where it overlaps with the axon initial segment (AIS), a critical region for controlling cargo entry into the axon [pan-2019-map7d2-proximal-axon-abstract].
Human MAP7D2 is a 773-amino acid protein (approximately 82 kDa) sharing the characteristic structural organization of MAP7 family members [pan-2019-map7d2-proximal-axon-summary]. The protein contains two principal functional domains connected by an unstructured linker region. The N-terminal domain harbors a conserved coiled-coil motif that mediates direct binding to microtubules, while the C-terminal domain contains a second coiled-coil region responsible for interaction with the stalk region of kinesin-1 heavy chains [hooikaas-2019-map7-kinesin-abstract].
Structure-function studies have demonstrated that the N-terminal microtubule-binding domain (approximately amino acids 151-387) is sufficient for directing MAP7D2 to its characteristic subcellular localization at the proximal axon [pan-2019-map7d2-proximal-axon-summary]. Truncation constructs lacking this region show diffuse cytoplasmic distribution, while the isolated N-terminal fragment recapitulates the proximal axon accumulation pattern [pan-2019-map7d2-proximal-axon-summary]. The C-terminal kinesin-binding domain, when expressed alone, distributes diffusely throughout the neuron and accumulates at axon tips, likely reflecting transport by kinesin-1 [pan-2019-map7d2-proximal-axon-summary].
While no high-resolution structure of MAP7D2 itself has been determined, structural insights from the founding family member MAP7 provide relevant context. Cryo-electron microscopy studies revealed that the MAP7 microtubule-binding domain (MTBD) binds microtubules as an extended alpha-helix positioned between the protofilament ridge and the site of lateral contact [ferro-2022-map7-structure-abstract]. This binding site partially overlaps with the kinesin-1 binding site on microtubules, leading to complex regulatory consequences [ferro-2022-map7-structure-abstract].
The primary molecular function of MAP7D2 is direct binding to microtubules, which it accomplishes through its N-terminal region. Using recombinant rat MAP7D2 protein, Kikuchi and colleagues demonstrated that MAP7D2 binds to microtubules through its N-terminal half and facilitates microtubule stabilization in vitro [kikuchi-2022-map7d2-stabilization-abstract]. Quantitative analysis using microtubule co-sedimentation assays determined that MAP7D2 binds microtubules with a dissociation constant (Kd) of approximately 6 Γ 10β»β· M (600 nM), which is comparable to the binding affinities of well-characterized MAPs such as tau and CLIP-170 [kikuchi-2022-map7d2-stabilization-abstract]. The stoichiometry of MAP7D2 binding to tubulin was calculated to be one MAP7D2 molecule per approximately 10 tubulin Ξ±/Ξ² heterodimers, a ratio also comparable to that observed for MAP7 [kikuchi-2022-map7d2-stabilization-abstract].
Importantly, MAP7D2 employs a distinct mechanism of microtubule stabilization compared to its paralog MAP7D1. When MAP7D2 is depleted from cells, resistance to the microtubule-destabilizing agent nocodazole decreases without affecting levels of acetylated or detyrosinated tubulin, which are markers of stable microtubule populations [kikuchi-2022-map7d2-stabilization-summary]. This finding indicates that MAP7D2 stabilizes microtubules via direct physical binding rather than by promoting post-translational modifications. In contrast, MAP7D1 is required for maintaining acetylated stable microtubules, demonstrating that these paralogs have evolved mechanistically distinct approaches to microtubule regulation [kikuchi-2022-map7d2-stabilization-abstract].
Beyond microtubule stabilization, MAP7D2 functions as a critical cofactor for kinesin-1 motor function. Biochemical studies have demonstrated that MAP7D2 interacts with all three mammalian kinesin-1 family members (KIF5A, KIF5B, and KIF5C) through pull-down experiments and mass spectrometry [pan-2019-map7d2-proximal-axon-abstract]. Notably, MAP7D2 does not interact with kinesin-3 motors, indicating specificity in its motor regulation [pan-2019-map7d2-proximal-axon-summary].
The mechanism by which MAP7 family proteins activate kinesin-1 has been elucidated through extensive in vitro reconstitution studies. These proteins enhance both the microtubule landing rate and processivity of kinesin-1 motors through a dual mechanism [hooikaas-2019-map7-kinesin-summary]. First, they directly recruit kinesin-1 to microtubules through their N-terminal microtubule-binding domain and unstructured linker region. Second, they exert an allosteric activation effect through their C-terminal kinesin-binding domain [hooikaas-2019-map7-kinesin-abstract]. The C-terminal domain alone can efficiently increase kinesin-1 landing rates despite having minimal microtubule affinity, demonstrating that the activation mechanism involves more than simple tethering [hooikaas-2019-map7-kinesin-summary].
A distinguishing feature of MAP7D2 is its specific localization to the proximal axon in neurons, a pattern that differentiates it from other MAP7 family members. While MAP7 and MAP7D1 are predominantly found in the somatodendritic compartment, MAP7D2 and MAP7D3 concentrate at the proximal axon where they overlap with AIS markers including TRIM46 and Ankyrin-G [pan-2019-map7d2-proximal-axon-abstract].
The proximal axon localization of MAP7D2 depends critically on TRIM46, a microtubule-bundling protein that organizes parallel microtubule arrays at the AIS. When TRIM46 is depleted, MAP7D2 fails to accumulate at the proximal axon [pan-2019-map7d2-proximal-axon-summary]. This dependency suggests that MAP7D2 may recognize specific modifications or conformational changes in the microtubule lattice induced by TRIM46-mediated bundling, rather than simply binding to any available microtubule [pan-2019-map7d2-proximal-axon-summary].
In addition to its axonal localization, MAP7D2 prominently localizes to the centrosome and distributes partially along cytoplasmic microtubules in neuronal cells [kikuchi-2022-map7d2-stabilization-abstract]. This centrosomal enrichment suggests potential roles in microtubule nucleation or organization emanating from this microtubule-organizing center. The protein accumulates at sites of active microtubule bundling during cell division and neurite formation, consistent with its function as a microtubule-binding and stabilizing protein [kikuchi-2022-map7d2-stabilization-summary].
The strategic localization of MAP7D2 at the proximal axon positions it to regulate a critical decision point in neuronal cargo sorting. The axon initial segment serves as a gateway controlling which cargoes enter the axon versus remaining in the somatodendritic compartment. MAP7D2 functions at this location to locally promote kinesin-1-mediated cargo entry into the axon [pan-2019-map7d2-proximal-axon-abstract].
Depletion of MAP7D2 significantly reduces axonal entry of kinesin-1-dependent cargoes, including mitochondria, lysosomes, and endoplasmic reticulum [pan-2019-map7d2-proximal-axon-summary]. This transport defect is specific to kinesin-1-dependent processes, as Rab3-positive vesicles that depend on kinesin-3 for transport are unaffected by MAP7D2 loss [pan-2019-map7d2-proximal-axon-summary]. The proposed model suggests that MAP7D2 acts as a spatially restricted activator of kinesin-1, enhancing motor recruitment and activity specifically at the proximal axon to facilitate cargo transition from the soma into the axonal compartment.
Loss-of-function studies have revealed that MAP7D2 plays important roles in regulating cell migration and neurite extension. Unexpectedly, MAP7D2 depletion or knockout leads to increased rates of random cell migration and neurite outgrowth [kikuchi-2022-map7d2-stabilization-summary]. This seemingly paradoxical result is interpreted as reflecting a disturbance in the balance between microtubule stabilization and destabilization, with excessive dynamicity promoting these processes [kikuchi-2022-map7d2-stabilization-summary].
In developing neurons, MAP7D2 depletion causes reduced axon branching and defects in axon formation and outgrowth [pan-2019-map7d2-proximal-axon-abstract]. These phenotypes can be rescued by re-expression of MAP7D2 but not by MAP7D1, despite the two proteins sharing significant sequence homology [pan-2019-map7d2-proximal-axon-summary]. This specificity likely reflects their distinct subcellular localizations, with MAP7D1 unable to compensate for MAP7D2 function at the proximal axon.
During brain development, MAP7D2 contributes to proper neuronal migration. Depletion of MAP7D2 results in migration defects in embryonic brain slices, indicating that the protein's function in regulating microtubule stability and kinesin-1-mediated transport is important for the cellular motility required during cortical development [pan-2019-map7d2-proximal-axon-abstract].
MAP7D2 exhibits a highly restricted tissue expression pattern, being detected primarily in brain and testis, with brain expression being more abundant [kikuchi-2022-map7d2-stabilization-abstract]. This pattern contrasts with MAP7, which shows more ubiquitous expression. Within the brain, MAP7D2 is highly expressed in the glomerular layer of the olfactory bulb, a region characterized by dense accumulation of axons from olfactory sensory neurons [kikuchi-2022-map7d2-stabilization-summary]. This localization pattern is consistent with the protein's function in axonal biology.
In the testis, MAP7D2 is expressed specifically in Sertoli cells, the somatic support cells of the seminiferous epithelium that nurture developing germ cells [kikuchi-2022-map7d2-stabilization-summary]. The functional significance of MAP7D2 in Sertoli cells has not been extensively characterized, but given the importance of microtubule-based transport in these cells for supporting spermatogenesis, MAP7D2 likely contributes to cargo transport processes within this specialized cell type.
At the cellular level in neurons, MAP7D2 shows expression enriched in hippocampal neurons, where it localizes specifically to the proximal axon through its N-terminal microtubule-binding domain [pan-2019-map7d2-proximal-axon-summary]. The Human Protein Atlas reports cytoplasmic expression in neurons and cells of the seminiferous duct testis, with some nuclear/nucleoplasmic localization also observed.
Understanding MAP7D2 requires appreciation of its position within the larger MAP7 protein family. All four mammalian family members share the conserved domain architecture with N-terminal microtubule-binding and C-terminal kinesin-binding regions [hooikaas-2019-map7-kinesin-abstract]. They all function as positive regulators of kinesin-1, in contrast to classical neuronal MAPs such as tau and MAP2 that inhibit kinesin-1-driven motility [hooikaas-2019-map7-kinesin-summary].
Despite these shared features, the family members exhibit important functional specialization. MAP7 is immobile on microtubules and requires high local density to affect kinesin-1 processivity, while MAP7D3 has higher kinesin-1 affinity but lower microtubule affinity and can be co-transported with motors [hooikaas-2019-map7-kinesin-summary]. The subcellular localization patterns also differ markedly: MAP7 and MAP7D1 localize to the somatodendritic compartment, while MAP7D2 and MAP7D3 concentrate at the proximal axon [pan-2019-map7d2-proximal-axon-abstract].
In terms of microtubule stabilization mechanisms, MAP7D2 and MAP7D1 employ distinct approaches despite both promoting stability. MAP7D2 operates through direct binding to the microtubule lattice, while MAP7D1 maintains stability through preserving acetylated tubulin populations [kikuchi-2022-map7d2-stabilization-summary]. This mechanistic diversity may allow for nuanced control of microtubule dynamics in different cellular contexts.
The MAP7 family represents an evolutionarily conserved class of kinesin-1 regulators. In Drosophila, a single homolog called ensconsin (also known as E-MAP-115) performs the functions that are distributed among four paralogs in mammals [hooikaas-2019-map7-kinesin-abstract]. Studies of Drosophila ensconsin have been instrumental in establishing the essential role of this protein family in kinesin-1-dependent processes.
Ensconsin is required for all known kinesin-1-dependent processes in Drosophila, including spindle positioning, centrosome separation, and polarized cargo transport in oocytes [metivier-2019-ensconsin-abstract]. The fly protein shares the same domain architecture as mammalian MAP7D2, with an N-terminal microtubule-binding domain and a C-terminal kinesin-binding domain. Mechanistic studies in Drosophila revealed that the kinesin-binding domain alone can stimulate kinesin-1 targeting to microtubules both in vivo and in vitro, while full-length ensconsin provides optimal motor recruitment through dual regulation involving both domains [metivier-2019-ensconsin-abstract].
The evolutionary expansion from a single ancestral ensconsin gene in invertebrates to four paralogs in mammals (MAP7, MAP7D1, MAP7D2, MAP7D3) appears to have enabled functional diversification. This diversification is manifest in the distinct subcellular localization patterns (somatodendritic versus axonal) and different mechanisms of microtubule stabilization (direct binding versus acetylation maintenance) exhibited by the mammalian paralogs. The conservation of the core biochemical functionsβmicrotubule binding and kinesin-1 activationβacross hundreds of millions of years of evolution underscores the fundamental importance of this regulatory mechanism in cellular biology.
The functional annotations for MAP7D2 in the Gene Ontology database reflect its characterized molecular activities and biological roles. In terms of Molecular Function, MAP7D2 is annotated with microtubule binding (GO:0008017) and kinesin binding, consistent with its demonstrated ability to directly interact with both microtubules and kinesin-1 motor proteins. The protein is also annotated with structural molecule activity, reflecting its role in stabilizing the microtubule cytoskeleton.
For Biological Process annotations, MAP7D2 is associated with microtubule cytoskeleton organization (GO:0000226) and axon development (GO:0061564). These annotations capture its roles in maintaining microtubule stability and regulating axonal cargo transport during neuronal development.
Cellular Component annotations place MAP7D2 in the microtubule cytoskeleton (GO:0015630), axon (GO:0030424), and centrosome (GO:0005813), consistent with experimental observations of its subcellular localization in neuronal cells.
While no Mendelian diseases have been directly attributed to MAP7D2 mutations, emerging evidence links the protein to cancer biology. Recent work has identified MAP7D2 as significantly upregulated in microsatellite stable (MSS) colorectal cancer, where it adversely correlates with the presence of antitumor T lymphocytes [wu-2023-map7d2-colorectal-cancer-abstract].
Mechanistically, MAP7D2 binds to MYH9, a non-muscle myosin II heavy chain, and protects it from ubiquitin-mediated degradation [wu-2023-map7d2-colorectal-cancer-abstract]. This MAP7D2-mediated MYH9 stabilization reduces secretion of HMGB1, a damage-associated molecular pattern that normally acts as a chemokine to recruit T lymphocytes into the tumor microenvironment. Consequently, elevated MAP7D2 expression promotes an immunosuppressive microenvironment by reducing CD8+ cytotoxic T lymphocyte infiltration [wu-2023-map7d2-colorectal-cancer-abstract].
From a therapeutic perspective, knockdown of MAP7D2 in colorectal cancer models significantly increases CD8+ T cell infiltration, inhibits tumor progression, and improves the efficacy of immune checkpoint inhibitors such as anti-PD-1 antibodies [wu-2023-map7d2-colorectal-cancer-abstract]. This work suggests that MAP7D2 may represent a potential therapeutic target for improving immunotherapy responses in MSS colorectal cancer, a tumor type that typically responds poorly to checkpoint blockade.
The Human Protein Atlas classifies MAP7D2 as a prognostic marker in bladder urothelial carcinoma and pancreatic adenocarcinoma, though the protein shows relatively low cancer specificity overall. Database associations also link MAP7D2 to esophageal adenosquamous carcinoma, though detailed mechanistic studies in these cancer types are lacking.
Several important questions remain regarding MAP7D2 biology:
Structural basis of MAP7D2 function: While structural studies of MAP7 have provided insights into microtubule binding and kinesin-1 regulation, high-resolution structures of MAP7D2 specifically would clarify whether the family members employ identical or distinct molecular mechanisms.
TRIM46-dependent localization mechanism: The molecular basis by which MAP7D2 recognizes TRIM46-organized microtubule bundles at the AIS remains unclear. Whether this involves direct TRIM46 interaction, recognition of specific tubulin post-translational modifications, or sensing of microtubule geometry warrants investigation.
Testis function: The specific role of MAP7D2 in Sertoli cells is essentially uncharacterized. Given the importance of microtubule-based transport in supporting spermatogenesis, understanding MAP7D2 function in this context could reveal important reproductive biology.
Centrosomal function: The prominent centrosomal localization of MAP7D2 suggests potential roles beyond axonal transport, possibly in microtubule nucleation or organization. These potential functions remain unexplored.
Disease relevance beyond cancer: Whether MAP7D2 dysfunction contributes to neurological or neurodevelopmental disorders, given its critical roles in axonal biology, merits systematic investigation.
Regulation of MAP7D2: The mechanisms controlling MAP7D2 expression, localization, and activity are poorly understood. Post-translational modifications or binding partners that modulate its function have not been characterized.
Functional redundancy vs. specificity: While MAP7 family members show functional redundancy in some assays, the distinct localization patterns and mechanisms suggest specialized roles that warrant further delineation.
[kikuchi-2022-map7d2-stabilization] Kikuchi K, Sakamoto Y, Uezu A, Yamamoto H, Ishiguro KI, Shimamura K, Saito T, Hisanaga SI, Nakanishi H. Map7D2 and Map7D1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells. Life Sci Alliance. 2022 Apr 25;5(8):e202201390. PMID: 35470240; PMCID: PMC9039348; DOI: 10.26508/lsa.202201390. URL: https://www.life-science-alliance.org/content/5/8/e202201390
[pan-2019-map7d2-proximal-axon] Pan X, Cao Y, Stucchi R, Hooikaas PJ, Portegies S, Will L, Martin M, Akhmanova A, Harterink M, Hoogenraad CC. MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-Mediated Cargo Transport into the Axon. Cell Rep. 2019 Feb 19;26(8):1988-1999.e6. PMID: 30784582; PMCID: PMC6381606; DOI: 10.1016/j.celrep.2019.01.084. URL: https://www.sciencedirect.com/science/article/pii/S2211124719301202
[hooikaas-2019-map7-kinesin] Hooikaas PJ, Martin M, MΓΌhlethaler T, Kuijntjes GJ, Peeters CAE, Katrukha EA, Ferrari L, Stucchi R, Verhagen DGF, van Riel WE, Grigoriev I, Altelaar AFM, Hoogenraad CC, RΓΌdiger SGD, Steinmetz MO, Kapitein LC, Akhmanova A. MAP7 family proteins regulate kinesin-1 recruitment and activation. J Cell Biol. 2019 Apr 1;218(4):1298-1318. PMID: 30770434; PMCID: PMC6446838; DOI: 10.1083/jcb.201808065. URL: https://rupress.org/jcb/article/218/4/1298/61853/MAP7-family-proteins-regulate-kinesin-1
[ferro-2022-map7-structure] Ferro LS, Fang Q, Eshun-Wilson L, Fernandes J, et al. Structural and functional insight into regulation of kinesin-1 by microtubule-associated protein MAP7. Science. 2022 Jan 21;375(6578):326-331. PMID: 35050657; PMCID: PMC8985661; DOI: 10.1126/science.abf6154. URL: https://www.science.org/doi/10.1126/science.abf6154
[tymanskyj-2018-map7-axon] Tymanskyj SR, Yang BH, Verhey KJ, Ma L. MAP7 regulates axon morphogenesis by recruiting kinesin-1 to microtubules and modulating organelle transport. eLife. 2018;7:e36374. PMID: 30015618; PMCID: PMC6133550; DOI: 10.7554/eLife.36374. URL: https://elifesciences.org/articles/36374
[wu-2023-map7d2-colorectal-cancer] Wu Q, Yue X, Liu H, Zhu Y, Ke H, Yang X, Yin S, Li Z, Zhang Y, Hu T, Lan P, Wu X. MAP7D2 reduces CD8+ cytotoxic T lymphocyte infiltration through MYH9-HMGB1 axis in colorectal cancer. Mol Ther. 2023 Jan 4;31(1):90-104. PMID: 36081350; PMCID: PMC9840115; DOI: 10.1016/j.ymthe.2022.09.001. URL: https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(22)00544-1
[metivier-2019-ensconsin] MΓ©tivier M, Monroy BY, Gallaud E, et al. Dual control of Kinesin-1 recruitment to microtubules by Ensconsin in Drosophila neuroblasts and oocytes. Development. 2019 Apr 17;146(8):dev171579. PMID: 30936181; PMCID: PMC6503980; DOI: 10.1242/dev.171579. URL: https://pubmed.ncbi.nlm.nih.gov/30936181/
[omim-301121] OMIM Entry 301121: MAP7 DOMAIN-CONTAINING PROTEIN 2; MAP7D2. URL: https://omim.org/entry/301121
[uniprot-q96t17] UniProt Entry Q96T17: MAP7 domain-containing protein 2 - Homo sapiens (Human). URL: https://www.uniprot.org/uniprotkb/Q96T17/entry
[human-protein-atlas-map7d2] Human Protein Atlas: MAP7D2 protein expression summary. URL: https://www.proteinatlas.org/ENSG00000184368-MAP7D2
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Research report: MAP7D2 (UniProt Q96T17) β functional annotation and recent evidence
Verification of identity and family/domains
- Target identity: MAP7 domain-containing protein 2 (gene symbol MAP7D2) in Homo sapiens, a member of the MAP7/ensconsin family. Conserved architecture across MAP7 paralogs includes an N-terminal microtubule-binding region and a C-terminal kinesin-1βinteracting region, consistent with MAP7 family domain organization and function. Neuronal studies identify MAP7D2 as the paralog concentrated at the proximal axon. These features align with the UniProt description and MAP7-family domain expectations (N-terminal MAP7 domain; MAP7 family). Evidence: in neurons, MAP7D2βs N-terminus binds microtubules; its C-terminus underlies kinesin-1 interaction, mirroring MAP7-family domain logic (Pan et al., Cell Reports, 2019; Kikuchi et al., Life Science Alliance preprint, 2022; Hooikaas et al., J Cell Biol, 2019) (pan2019map7d2localizesto pages 1-4, kikuchi2022map7d2andmap7d1 pages 4-7, hooikaas2019map7familyproteins pages 6-10).
Key concepts and definitions
- Molecular class: Microtubule-associated protein (MAP) of the MAP7 family. MAP7 family proteins act as microtubule-tethered activators that recruit and enhance kinesin-1 motility on microtubules. Mechanistically, MAP7-family members both promote kinesin-1 landing and increase processivity through direct and allosteric effects (Hooikaas et al., Feb 15, 2019; URL: https://doi.org/10.1083/jcb.201808065) (hooikaas2019map7familyproteins pages 6-10).
- Primary cellular role of MAP7D2: Local regulator of kinesin-1 at the proximal axon/axon initial segment (AIS), promoting kinesin-1βmediated cargo entry into the axon and influencing axon development and polarized transport (Pan et al., Feb 19, 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 1-4, pan2019map7d2localizesto pages 10-12).
Molecular function and mechanism
- Microtubule binding and stabilization: MAP7D2 directly binds microtubules via its N-terminal half and stabilizes microtubules. In neuronal cell models, MAP7D2 loss reduces nocodazole resistance (indicative of reduced MT stability) and increases neurite outgrowth and random migration, consistent with a role in tempering MT dynamics (Kikuchi et al., posted Mar 2, 2022; URL: https://doi.org/10.1101/2021.10.27.466197) (kikuchi2022map7d2andmap7d1 pages 4-7, kikuchi2022map7d2andmap7d1 pages 1-4, kikuchi2022map7d2andmap7d1 pages 38-38).
- Kinesin-1 interaction and activation: MAP7D2 interacts with kinesin-1 family members (KIF5A/B/C) and promotes their recruitment/activity on microtubules, gating anterograde transport into the axon. Depletion of MAP7D2 reduces kinesin-1βdependent axonal entry of multiple organelle cargos and alters KIF5 distribution at the axon start (Pan et al., 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 10-12, pan2019map7d2localizesto pages 6-8, pan2019map7d2localizesto pages 1-4).
- Distinct mechanism within MAP7 family: Compared with MAP7D1, MAP7D2 stabilizes microtubules primarily through direct binding rather than maintaining acetylated tubulin; both can form complexes with Kif5b, but their stabilization mechanisms diverge (Kikuchi et al., 2022; URL: https://doi.org/10.1101/2021.10.27.466197) (kikuchi2022map7d2andmap7d1 pages 9-12, kikuchi2022map7d2andmap7d1 pages 4-7, kikuchi2022map7d2andmap7d1 pages 38-38).
Cellular localization
- Proximal axon/AIS enrichment: MAP7D2 concentrates at the proximal axon (overlapping the AIS region) in developing hippocampal neurons, positioning it to modulate the axonal transport gate (Pan et al., 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 1-4, pan2019map7d2localizesto pages 10-12).
- Additional subcellular sites: In neuronal cell lines, MAP7D2 is prominent at centrosomes and partially along microtubules; accumulates in neurites and at the midbody during cytokinesis (Kikuchi et al., 2022; URL: https://doi.org/10.1101/2021.10.27.466197) (kikuchi2022map7d2andmap7d1 pages 7-9).
Pathway context and biological processes
- Axon polarity and transport gating: By locally recruiting/activating kinesin-1 on proximal-axon microtubules, MAP7D2 facilitates polarized entry of cargoes (mitochondria, lysosomes, ER-derived organelles) into axons, thereby contributing to axon formation, branching, and neuronal migration (Pan et al., 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 1-4, pan2019map7d2localizesto pages 10-12, pan2019map7d2localizesto pages 6-8).
- MAP7 family in transport regulation: Broadly, MAP7 paralogs regulate kinesin-1 landing and processivity; MAP7D3 shows higher kinesin-1 affinity and mobility than MAP7, illustrating paralog-specific modulation of kinesin mechanics (Hooikaas et al., 2019; URL: https://doi.org/10.1083/jcb.201808065) (hooikaas2019map7familyproteins pages 6-10).
Recent developments and latest research (emphasis 2023β2024)
- Human genetics (2023): An X-chromosome GWAS in UK Biobank identified MAP7D2 as significantly associated with age-related hearing loss (lead variant rs4370706 p = 2.3Γ10β8; combined OR ~1.03), with supporting expression in mouse and adult human inner ear tissues, particularly inner hair cells (Naderi et al., Feb 21, 2023; URL: https://doi.org/10.3389/fgene.2023.1106328) (naderi2023thegeneticcontribution pages 1-2, naderi2023thegeneticcontribution pages 4-6).
- Kinesin regulation framework (continuing relevance): Mechanistic principles of MAP7-family regulation of kinesin-1 recruitment/activation remain foundational for interpreting MAP7D2βs axonal gate role (Hooikaas et al., 2019; URL: https://doi.org/10.1083/jcb.201808065) (hooikaas2019map7familyproteins pages 6-10).
Current applications and real-world implementations
- Genetic association and inner ear biology: The MAP7D2 ARHL association supports follow-up functional studies in sensory hair cells and could inform risk stratification or mechanistic studies of cochlear transport and homeostasis (Naderi et al., 2023; URL: https://doi.org/10.3389/fgene.2023.1106328) (naderi2023thegeneticcontribution pages 1-2, naderi2023thegeneticcontribution pages 4-6).
- Oncology transcriptomics: Analyses of public NSCLC datasets report MAP7D2 mRNA upregulation in lung cancer tissues (e.g., 5.45-fold in a large-cell carcinoma dataset, p = 1.33Γ10β6; 6.79-fold in a lung adenocarcinoma dataset, p = 4.31Γ10β11), with broader exploration of MAPs in prognosis and immunotherapy response. While MAP7D2 itself showed limited prognostic association in that study, elevated expression supports its use as a transcriptomic variable in lung cancer research (Luo et al., Oct 27, 2021; URL: https://doi.org/10.3389/fonc.2021.680402) (luo2021expressionofmicrotubuleassociated pages 5-9).
Expert opinions and analysis from authoritative sources
- JCB mechanistic study: Hooikaas et al. propose MAP7 proteins as microtubule-tethered kinesin-1 activators, acting through both direct MT tethering and an allosteric kinesin-1βbinding C-terminus. This dual mechanism rationalizes how MAP7D2 could locally bias kinesin-1 engagement in the proximal axon (Hooikaas et al., 2019; URL: https://doi.org/10.1083/jcb.201808065) (hooikaas2019map7familyproteins pages 6-10).
- Cell Reports neuronal study: Pan et al. argue that MAP7D2 functions specifically at the proximal axon to promote kinesin-1βmediated cargo entry and axon development, establishing a localized transport control point integral to neuronal polarity (Pan et al., 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 1-4, pan2019map7d2localizesto pages 10-12).
- MAP7D2 stabilization mechanism: Kikuchi et al. highlight paralog-specific MT stabilization mechanisms, with MAP7D2 acting via direct MT binding and MAP7D1 supporting acetylated MTsβan important nuance for interpreting phenotypes across tissues and contexts (Kikuchi et al., 2022; URL: https://doi.org/10.1101/2021.10.27.466197) (kikuchi2022map7d2andmap7d1 pages 9-12, kikuchi2022map7d2andmap7d1 pages 4-7, kikuchi2022map7d2andmap7d1 pages 38-38).
Relevant statistics and quantitative data
- GWAS (ARHL, X chromosome): Lead MAP7D2 variant rs4370706 reached genome-wide significance (p = 2.3Γ10β8). X-chromosome variants collectively explained ~0.4% of ARHL variance in the dataset (SE 0.8%, p = 3.5Γ10β6). Reported combined OR for MAP7D2 locus ~1.03 (95% CI 1.016β1.045). Expression evidence included mouse inner ear and adult human inner ear (Naderi et al., 2023; URL: https://doi.org/10.3389/fgene.2023.1106328) (naderi2023thegeneticcontribution pages 1-2, naderi2023thegeneticcontribution pages 4-6).
- Cancer transcriptomics (NSCLC datasets): MAP7D2 mRNA fold-change upregulation reported as 5.453 (p = 1.33Γ10β6; Hou Lung dataset) and 6.785 (p = 4.31Γ10β11; Okayama Lung) relative to normal tissues (Luo et al., 2021; URL: https://doi.org/10.3389/fonc.2021.680402) (luo2021expressionofmicrotubuleassociated pages 5-9).
- Biochemical/biophysical (MAP7D2 MT binding): Microtubule co-sedimentation determined an apparent KD on the order of ~6Γ10β7 M and a binding stoichiometry of approximately one MAP7D2 per ~10 Ξ±/Ξ²-tubulin heterodimers for recombinant protein in vitro (Kikuchi et al., 2022; URL: https://doi.org/10.1101/2021.10.27.466197) (kikuchi2022map7d2andmap7d1 pages 4-7).
- Cell biological readouts (neurons): MAP7D2 depletion reduced KIF5C intensity at the axon start and diminished axonal entry of organelle cargos; sample sizes per condition ranged roughly from n β 15β32 neurons with statistical significance thresholds noted (Pan et al., 2019; URL: https://doi.org/10.1016/j.celrep.2019.01.084) (pan2019map7d2localizesto pages 10-12).
Notes on symbol specificity and organism
- Ambiguity check: MAP7D2 can refer to different speciesβ orthologs in publications. The human identity (UniProt Q96T17) aligns with the MAP7 family architecture described above. Much mechanistic work (Pan et al., Kikuchi et al.) used rodent neuronal systems to elucidate a conserved function that is consistent with human MAP7D2 domain structure and the familyβs kinesin-1βmodulatory role. No conflicting gene of the same symbol in a different organism was identified that would invalidate the human MAP7D2 context considered here (pan2019map7d2localizesto pages 1-4, kikuchi2022map7d2andmap7d1 pages 4-7).
Summary
- MAP7D2 is a human MAP7-family microtubule-associated protein localized to the proximal axon/AIS, where it recruits/activates kinesin-1 to promote anterograde cargo entry, contributing to axon development and polarized transport. It directly binds and stabilizes microtubules via its N-terminus and associates with kinesin-1 via its conserved C-terminus. Recent human genetics implicate MAP7D2 in age-related hearing loss, supported by inner-ear expression. Cancer transcriptomics report MAP7D2 upregulation in NSCLC datasets, though prognostic impact for MAP7D2 itself is limited in that study. Together, these data support a core role for MAP7D2 in microtubule-based transport gating at the proximal axon with disease relevance emerging in sensory hearing biology and oncology transcriptomics (Pan 2019: https://doi.org/10.1016/j.celrep.2019.01.084; Hooikaas 2019: https://doi.org/10.1083/jcb.201808065; Kikuchi 2022: https://doi.org/10.1101/2021.10.27.466197; Naderi 2023: https://doi.org/10.3389/fgene.2023.1106328; Luo 2021: https://doi.org/10.3389/fonc.2021.680402) (pan2019map7d2localizesto pages 1-4, hooikaas2019map7familyproteins pages 6-10, kikuchi2022map7d2andmap7d1 pages 4-7, naderi2023thegeneticcontribution pages 1-2, luo2021expressionofmicrotubuleassociated pages 5-9).
References
(pan2019map7d2localizesto pages 1-4): Xingxiu Pan, Yujie Cao, Riccardo Stucchi, Peter Jan Hooikaas, Sybren Portegies, Lena Will, Maud Martin, Anna Akhmanova, Martin Harterink, and Casper C. Hoogenraad. Map7d2 localizes to the proximal axon and locally promotes kinesin-1-mediated cargo transport into the axon. Cell Reports, 26:1988-1999.e6, Feb 2019. URL: https://doi.org/10.1016/j.celrep.2019.01.084, doi:10.1016/j.celrep.2019.01.084. This article has 52 citations and is from a highest quality peer-reviewed journal.
(kikuchi2022map7d2andmap7d1 pages 4-7): Koji Kikuchi, Yasuhisa Sakamoto, Akiyoshi Uezu, Hideyuki Yamamoto, Kei-ichiro Ishiguro, Kenji Shimamura, Taro Saito, Shin-ichi Hisanaga, and Hiroyuki Nakanishi. Map7d2 and map7d1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells. Life Science Alliance, Mar 2022. URL: https://doi.org/10.1101/2021.10.27.466197, doi:10.1101/2021.10.27.466197. This article has 1 citations and is from a peer-reviewed journal.
(hooikaas2019map7familyproteins pages 6-10): Peter Jan Hooikaas, Maud Martin, Tobias MΓΌhlethaler, Gert-Jan Kuijntjes, Cathelijn A.E. Peeters, Eugene A. Katrukha, Luca Ferrari, Riccardo Stucchi, Daan G.F. Verhagen, Wilhelmina E. van Riel, Ilya Grigoriev, A.F. Maarten Altelaar, Casper C. Hoogenraad, Stefan G.D. RΓΌdiger, Michel O. Steinmetz, Lukas C. Kapitein, and Anna Akhmanova. Map7 family proteins regulate kinesin-1 recruitment and activation. Journal of Cell Biology, 218:1298-1318, Feb 2019. URL: https://doi.org/10.1083/jcb.201808065, doi:10.1083/jcb.201808065. This article has 170 citations and is from a highest quality peer-reviewed journal.
(pan2019map7d2localizesto pages 10-12): Xingxiu Pan, Yujie Cao, Riccardo Stucchi, Peter Jan Hooikaas, Sybren Portegies, Lena Will, Maud Martin, Anna Akhmanova, Martin Harterink, and Casper C. Hoogenraad. Map7d2 localizes to the proximal axon and locally promotes kinesin-1-mediated cargo transport into the axon. Cell Reports, 26:1988-1999.e6, Feb 2019. URL: https://doi.org/10.1016/j.celrep.2019.01.084, doi:10.1016/j.celrep.2019.01.084. This article has 52 citations and is from a highest quality peer-reviewed journal.
(kikuchi2022map7d2andmap7d1 pages 1-4): Koji Kikuchi, Yasuhisa Sakamoto, Akiyoshi Uezu, Hideyuki Yamamoto, Kei-ichiro Ishiguro, Kenji Shimamura, Taro Saito, Shin-ichi Hisanaga, and Hiroyuki Nakanishi. Map7d2 and map7d1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells. Life Science Alliance, Mar 2022. URL: https://doi.org/10.1101/2021.10.27.466197, doi:10.1101/2021.10.27.466197. This article has 1 citations and is from a peer-reviewed journal.
(kikuchi2022map7d2andmap7d1 pages 38-38): Koji Kikuchi, Yasuhisa Sakamoto, Akiyoshi Uezu, Hideyuki Yamamoto, Kei-ichiro Ishiguro, Kenji Shimamura, Taro Saito, Shin-ichi Hisanaga, and Hiroyuki Nakanishi. Map7d2 and map7d1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells. Life Science Alliance, Mar 2022. URL: https://doi.org/10.1101/2021.10.27.466197, doi:10.1101/2021.10.27.466197. This article has 1 citations and is from a peer-reviewed journal.
(pan2019map7d2localizesto pages 6-8): Xingxiu Pan, Yujie Cao, Riccardo Stucchi, Peter Jan Hooikaas, Sybren Portegies, Lena Will, Maud Martin, Anna Akhmanova, Martin Harterink, and Casper C. Hoogenraad. Map7d2 localizes to the proximal axon and locally promotes kinesin-1-mediated cargo transport into the axon. Cell Reports, 26:1988-1999.e6, Feb 2019. URL: https://doi.org/10.1016/j.celrep.2019.01.084, doi:10.1016/j.celrep.2019.01.084. This article has 52 citations and is from a highest quality peer-reviewed journal.
(kikuchi2022map7d2andmap7d1 pages 9-12): Koji Kikuchi, Yasuhisa Sakamoto, Akiyoshi Uezu, Hideyuki Yamamoto, Kei-ichiro Ishiguro, Kenji Shimamura, Taro Saito, Shin-ichi Hisanaga, and Hiroyuki Nakanishi. Map7d2 and map7d1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells. Life Science Alliance, Mar 2022. URL: https://doi.org/10.1101/2021.10.27.466197, doi:10.1101/2021.10.27.466197. This article has 1 citations and is from a peer-reviewed journal.
(kikuchi2022map7d2andmap7d1 pages 7-9): Koji Kikuchi, Yasuhisa Sakamoto, Akiyoshi Uezu, Hideyuki Yamamoto, Kei-ichiro Ishiguro, Kenji Shimamura, Taro Saito, Shin-ichi Hisanaga, and Hiroyuki Nakanishi. Map7d2 and map7d1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells. Life Science Alliance, Mar 2022. URL: https://doi.org/10.1101/2021.10.27.466197, doi:10.1101/2021.10.27.466197. This article has 1 citations and is from a peer-reviewed journal.
(naderi2023thegeneticcontribution pages 1-2): Elnaz Naderi, Diana M. Cornejo-Sanchez, Guangyou Li, Isabelle Schrauwen, Gao T. Wang, Andrew T. Dewan, and Suzanne M. Leal. The genetic contribution of the x chromosome in age-related hearing loss. Frontiers in Genetics, Feb 2023. URL: https://doi.org/10.3389/fgene.2023.1106328, doi:10.3389/fgene.2023.1106328. This article has 3 citations and is from a peer-reviewed journal.
(naderi2023thegeneticcontribution pages 4-6): Elnaz Naderi, Diana M. Cornejo-Sanchez, Guangyou Li, Isabelle Schrauwen, Gao T. Wang, Andrew T. Dewan, and Suzanne M. Leal. The genetic contribution of the x chromosome in age-related hearing loss. Frontiers in Genetics, Feb 2023. URL: https://doi.org/10.3389/fgene.2023.1106328, doi:10.3389/fgene.2023.1106328. This article has 3 citations and is from a peer-reviewed journal.
(luo2021expressionofmicrotubuleassociated pages 5-9): Jieyan Luo, Qipeng Hu, Maling Gou, Xiaoke Liu, Yi Qin, Jiao Zhu, Chengzhi Cai, Tian Tian, Zegui Tu, Yijia Du, and Hongxin Deng. Expression of microtubule-associated proteins in relation to prognosis and efficacy of immunotherapy in non-small cell lung cancer. Frontiers in Oncology, Oct 2021. URL: https://doi.org/10.3389/fonc.2021.680402, doi:10.3389/fonc.2021.680402. This article has 23 citations and is from a poor quality or predatory journal.
MAP7D2 is a human gene encoding the MAP7 domain-containing protein 2, a member of the microtubule-associated protein 7 (MAP7) family. This family (including MAP7/ensconsin, MAP7D1, MAP7D2, and MAP7D3) is characterized by a conserved domain organization with two major coiled-coil regions separated by a linker (pmc.ncbi.nlm.nih.gov). The N-terminal coiled-coil of MAP7 family proteins strongly binds to microtubules, while the C-terminal coiled-coil domain binds to the stalk region of kinesin-1 motor proteins (pmc.ncbi.nlm.nih.gov). In other words, MAP7D2 functions as a structural microtubule-associated protein (MAP) that can attach to microtubule filaments and simultaneously interact with kinesin motors. This dual-binding capability suggests MAP7D2 acts as an adapter or cofactor facilitating motor protein attachment and cargo transport along microtubules (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Consistent with this, MAP7D2 is predicted by databases to have kinesin binding activity and microtubule binding activity, and to be involved in axon development and microtubule cytoskeleton organization (www.ncbi.nlm.nih.gov).
MAP7D2 is a relatively specialized MAP7 family member with a restricted expression pattern. The human MAP7D2 gene is located on the X chromosome and has been reported as a maternally imprinted, brain-specific gene (pmc.ncbi.nlm.nih.gov). (Maternal imprinting indicates the maternal allele is silenced, so the gene is primarily expressed from the paternal X in females.) Indeed, MAP7D2 mRNA is predominantly expressed in the brain, with lower expression in testes, and little to no expression detected in most other tissues (pmc.ncbi.nlm.nih.gov). Northern blot analyses in rodents have shown a ~4.2 kb Map7d2 transcript present only in brain and testis, with brain having higher levels than testis (pmc.ncbi.nlm.nih.gov). Within the brain, MAP7D2 protein appears enriched in specific regions β for example, high expression is observed in the glomerular layer of the olfactory bulb and in Sertoli cells of the testis in mice (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This selective expression suggests MAP7D2 plays particularly important roles in neuronal cells and possibly in testicular cell function, rather than being a ubiquitous cytoskeletal protein.
Structurally, MAP7D2 belongs to the ensconsin/MAP7 family and shares the key domain features defining this group. Like its paralogs, MAP7D2 contains an N-terminal microtubule-binding domain (MTBD) β roughly on the order of 100β150 amino acids β that forms an Ξ±-helical structure binding along the microtubule lattice (www.nature.com). In the closely related MAP7 (ensconsin), this MT-binding segment (~112 amino acids, residues 59β170) binds at the interface of tubulin protofilaments, stabilizing microtubules and modulating their dynamics (www.nature.com). MAP7D2βs N-terminus is highly conserved with MAP7, suggesting a similar mode of microtubule attachment. The C-terminal region of MAP7D2 is a coiled-coil βMAP7 domainβ that mediates interactions with kinesin family motors (pmc.ncbi.nlm.nih.gov). Notably, biochemical studies have shown that MAP7D2 (like MAP7 and MAP7D1) binds directly to kinesin-1 (KIF5) heavy chains via this C-terminal region (pmc.ncbi.nlm.nih.gov). All three mammalian kinesin-1 isoforms (KIF5A, KIF5B, KIF5C) can associate with MAP7D2 (pmc.ncbi.nlm.nih.gov), likely through a direct binding to the kinesin stalk. This bridging of microtubules and kinesin-1 is a central concept in understanding MAP7D2βs function: it serves as a scaffold that recruits and activates motor proteins on microtubule tracks (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
Subcellular localization. In neurons, MAP7D2 displays a very distinctive subcellular localization. It concentrates at the proximal axon, overlapping with the axon initial segment (AIS) β the specialized segment at the axonβs base near the soma (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). When fluorescently tagged MAP7D2 is expressed in cultured neurons, it accumulates strongly at the proximal axonal region marked by AIS scaffolding proteins (such as TRIM46 and Ankyrin-G), and it is notably absent from distal axon regions where the axonal MAP Tau is abundant (pmc.ncbi.nlm.nih.gov). Endogenous MAP7D2 likewise shows a sharp enrichment at the AIS, as seen by immunostaining colocalized with Ankyrin-G (pmc.ncbi.nlm.nih.gov). Importantly, this localization emerges as neurons polarize: in early immature neurons (before a distinct axon is specified), MAP7D2 is found throughout neurites and cell bodies, but once an axon differentiates (stage 3 neurons), MAP7D2 becomes concentrated at the axonβs proximal segment (pmc.ncbi.nlm.nih.gov). This suggests a role tied specifically to the mature axon compartment.
The targeting of MAP7D2 to the proximal axon is driven by its microtubule-binding N-terminal domain. Deletion experiments have shown that MAP7D2βs N-terminus is necessary and sufficient for AIS targeting (pmc.ncbi.nlm.nih.gov). Truncated constructs containing only the N-terminal MT-binding region of MAP7D2 still accumulate at the proximal axon, whereas the C-terminal region alone does not show this localized enrichment (it distributes diffusely or in axon tips) (pmc.ncbi.nlm.nih.gov). Thus, the N-terminal domain confers selective binding to a subset of microtubules in the AIS region. This specificity may relate to unique properties of AIS microtubules β for example, their organization or post-translational modifications β or to local anchoring factors. Interestingly, MAP7D2βs closest paralog MAP7D3 shows a complementary expression pattern: MAP7D3 is largely absent from brain neurons and instead is expressed in non-neuronal tissues (it is detectable in fibroblast/HeLa cells where MAP7D2 is not) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In line with that, MAP7D3 does not localize to the AIS but can bind microtubules elsewhere in cells. This mutual exclusivity suggests MAP7D2 and MAP7D3 might have evolved tissue-specific roles, with MAP7D2 specialized for the neuronal axon initial segment environment (pmc.ncbi.nlm.nih.gov).
Beyond neurons, MAP7D2 has been observed in certain other cellular contexts. In a mouse neuroblastoma cell line (N1-E115) that endogenously expresses MAP7D2, the protein was found to concentrate at the centrosome and also along microtubules radiating from it (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The centrosome localization may reflect a role in organizing microtubules in non-polarized cells or during neurite initiation. Notably, MAP7D2 did not appear at the midbody or cleavage furrow in dividing cultured cells (unlike some MAPs), consistent with its low or absent expression in most proliferating cell types (pmc.ncbi.nlm.nih.gov). Taken together, the evidence indicates MAP7D2 is predominantly a neuronal MAP, highly enriched at the axon initial segment and centrosomal microtubule-organizing center, where it can locally influence microtubule dynamics and motor function.
Tissue expression. At the whole organism level, MAP7D2 is mainly a brain-expressed gene. Transcript profiling and protein studies confirm highest expression in the central nervous system (pmc.ncbi.nlm.nih.gov). The brain-specific expression was also noted in human studies by Niida and Yachie (2011), who identified MAP7D2 as an X-linked, maternally imprinted gene expressed in the brain (pmc.ncbi.nlm.nih.gov). The imprinted status means expression from the maternal allele is suppressed, which is relatively unusual among human brain genes and underlines a tightly controlled regulation of MAP7D2. Outside the brain, the testis is the other site of significant MAP7D2 expression (pmc.ncbi.nlm.nih.gov). In particular, MAP7D2 protein is detected in Sertoli cells of the testes β these are supportive cells that have unique microtubule architectures for nourishing developing germ cells (pmc.ncbi.nlm.nih.gov). The functional significance in Sertoli cells remains unclear, but it might relate to maintaining the specialized cytoskeleton required for sperm maturation or positioning. Other adult tissues (heart, lung, liver, etc.) show negligible MAP7D2 expression by mRNA blotting (pmc.ncbi.nlm.nih.gov), which aligns with the idea that MAP7D2βs roles are not general to all cell types but rather confined to specific physiological systems (neuronal and reproductive).
One of the primary functions of MAP7D2 is the regulation of microtubule dynamics through direct binding and stabilization of microtubules. Microtubules continually switch between growth and shrinkage (dynamic instability), and MAPs often modulate this behavior. MAP7D2 stabilizes microtubules, as evidenced by cellular and in vitro assays. A recent 2022 study by Kikuchi et al. demonstrated that recombinant MAP7D2βs N-terminal half binds directly to microtubules and can enhance microtubule stability in vitro (pmc.ncbi.nlm.nih.gov). In cells, the loss of MAP7D2 leads to microtubules becoming more susceptible to depolymerization: specifically, MAP7D2 knockdown or knockout cells show decreased resistance to the microtubule-destabilizing drug nocodazole (pmc.ncbi.nlm.nih.gov). This indicates that MAP7D2 normally protects microtubules from disassembly, likely by physically reinforcing the microtubule lattice. Notably, MAP7D2βs stabilizing effect does not require inducing typical stable-tubule posttranslational modifications like acetylation or detyrosination (pmc.ncbi.nlm.nih.gov). In the absence of MAP7D2, overall levels of acetylated (long-lived) microtubules remain unchanged, yet microtubules are functionally less stable, suggesting MAP7D2 stabilizes microtubules through direct structural binding rather than by altering tubulinβs modification state (pmc.ncbi.nlm.nih.gov). This mechanism contrasts with its paralog MAP7D1: MAP7D1 was found to be necessary for maintaining acetylated, long-lived microtubules, whereas MAP7D2 stabilized microtubules even without affecting such modifications (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Thus, MAP7D2 and MAP7D1 stabilize microtubules via distinct mechanisms, highlighting a division of labor within the MAP7 family (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
Consistent with increased microtubule stability, MAP7D2 tends to restrain certain aspects of cell motility and growth that depend on microtubule dynamics. For example, Kikuchi et al. (2022) observed that knocking out Map7d2 in N1-E115 neuroblastoma cells led to faster random cell migration and enhanced neurite outgrowth compared to wild-type (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Normally, more stable microtubules correlate with a less migratory, more stationary cell phenotype, so the absence of MAP7D2 (and the resultant increase in microtubule dynamics) allowed cells to migrate and extend processes more rapidly. In neurons, microtubule stability is critical for maintaining axon structure and guiding gradual axon extension; too much instability can lead to exuberant but misdirected growth. The fact that MAP7D2 loss increases neurite outgrowth rate (pmc.ncbi.nlm.nih.gov) suggests that MAP7D2 helps put a check on microtubule dynamics, possibly ensuring that axon outgrowth is controlled and coordinated with other developmental events. Itβs worth noting that while loss of MAP7D2 yields longer neurites in culture, it also impairs proper axon formation and neuronal migration in developing neurons (discussed below), implying that the quality and organization of growth (not just speed) are compromised without this MAP (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Overall, these data support that MAP7D2 serves as a microtubule-stabilizing protein in cells, directly binding microtubule filaments to increase their stability and thereby influencing cell shape and motility.
At the molecular level, MAP7D2βs microtubule stabilization likely arises from its ability to both cross-link microtubules and guard the microtubule lattice. The N-terminal MT-binding domain can attach along the microtubule surface, which may prevent protofilament peeling or stabilize inter-protofilament contacts, akin to how classical MAPs like Tau stabilize microtubules (though via a different binding mode). Unlike Tau, however, MAP7 family proteins bind a distinct site on tubulin and can form extended stretches along the microtubule (www.nature.com). In Drosophila ensconsin (MAP7), overexpression causes microtubule bundling and resistance to depolymerizing treatments (pmc.ncbi.nlm.nih.gov), and mammalian MAP7D2 appears to share this ability to bolster microtubule integrity. Interestingly, some MAP7 family members have multiple MT-binding segments (e.g. MAP7D3 has an additional MT-binding region in its C-terminus) (pmc.ncbi.nlm.nih.gov), but MAP7D2 relies mainly on its conserved N-terminus for MT attachment. Through this mechanism, MAP7D2 helps establish a stable microtubule network in areas like the axon initial segment and centrosome, which may need a higher degree of microtubule rigidity and organization for their cellular functions.
Perhaps the most critical function of MAP7D2 in neurons is its role as a local regulator of kinesin-1 based transport. Kinesin-1 (conventional kinesin, KIF5 family) is the primary motor that carries cargo toward microtubule plus-ends, and in polarized neurons it is responsible for transporting vesicles and proteins selectively into axons. In a 2019 Cell Reports study, Pan et al. discovered that MAP7D2 is strategically positioned at the axon initial segment to promote kinesin-dependent cargo entry into the axon (pmc.ncbi.nlm.nih.gov). They showed that MAP7D2 directly interacts with kinesin-1 and is required for effective cargo trafficking from the soma into the axon (pmc.ncbi.nlm.nih.gov). Depleting MAP7D2 in cultured neurons led to a marked reduction in the movement of kinesin-1 cargo into axons, resulting in fewer vesicles reaching the axon and accumulating instead in the cell body (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This was accompanied by defects in axon development: neurons without MAP7D2 had shorter or misspecified axons and showed impaired neuronal migration during brain development (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These phenotypes underscore that MAP7D2 is essential for polarized vesicle transport, which in turn is needed for proper axon growth and for neurons to move to their correct positions in the developing brain.
Mechanistically, MAP7D2 acts as a kinesin-1 cofactor or adaptor at the AIS. The axon initial segment has been recognized as a gatekeeper for axonal transport β only select motors and cargo can efficiently enter the axon, ensuring the distinct composition of axons versus dendrites. MAP7D2 appears to facilitate this gating by recruiting kinesin-1 to AIS microtubules and enhancing its motility. Indeed, MAP7 (the founding family member) was previously identified as an βessential kinesin-1 cofactorβ that can tether kinesin to microtubules (pmc.ncbi.nlm.nih.gov). Similarly, MAP7D2 at the AIS can bind the passing kinesin-1 motors (via its C-terminus) and microtubules (via its N-terminus) simultaneously, effectively docking the motor onto the microtubule track in the right place. Pan et al. found that MAP7D2 concentrates at the proximal axon and overlaps with AIS markers, exactly where incoming kinesin-1 cargos would need assistance to enter (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Through co-immunoprecipitation and pull-down assays, they confirmed that MAP7D2 forms complexes with all three KIF5 motor isoforms (KIF5A/B/C) (pmc.ncbi.nlm.nih.gov). Notably, expressing MAP7D2 (or other MAP7 family proteins) in non-neuronal cells lacking them can rescue kinesinβs microtubule binding and transport activity, highlighting the sufficiency of MAP7 proteins in activating kinesin (pmc.ncbi.nlm.nih.gov). In contrast, MAP7D3 is less effective or behaves abnormally in this role (pmc.ncbi.nlm.nih.gov), suggesting that MAP7D2 (and MAP7/MAP7D1) are the primary positive regulators of kinesin-1.
A compelling model that has emerged is that MAP7D2 locally counteracts the inhibitory environment posed by other MAPs, thereby permitting kinesin-based transport into the axon. The axon is enriched with the MAP Tau (MAPT), especially in more distal regions, and Tau is known to impede kinesin-1 movement by occluding the microtubule surface (www.nature.com). How, then, do kinesins successfully travel in tau-rich axons? A likely answer is competition between MAPs: MAP7 family proteins can displace Tau and create tau-free βlanding patchesβ for kinesin. Studies on MAP7 (ensconsin) show that it competes with Tau for microtubule binding and can literally push Tau off the lattice (www.nature.com) (www.nature.com). By doing so, MAP7 frees up microtubule stretches where kinesin can attach and walk without being blocked. Moreover, MAP7 strongly recruits kinesin-1 to microtubules and even enhances its processive motility in vitro (www.nature.com). In neurons, knockdown of MAP7 causes opposite axonal phenotypes to Tau knockdown (more MAP7 leads to increased axonal growth, whereas more Tau restricts it) (www.nature.com). By extension, MAP7D2 at the axon initial segment likely plays a similar antagonistic role against dendritic MAPs, ensuring that kinesin motors engage microtubules in the proximal axon where Tau levels are lower and MAP7D2 is high. Indeed, Pan et al. (2019) proposed a model in which MAP7D2 at the AIS locally βlicensesβ kinesin-1 entry β essentially acting as a gatekeeper that promotes initial cargo entry into the axon (pmc.ncbi.nlm.nih.gov). This local regulation mechanism is increasingly recognized as an important principle: as experts have noted, specific MAPs can spatially control motor activity on microtubules as an βemerging conceptβ in cell biology (pmc.ncbi.nlm.nih.gov).
It is important to note that MAP7D2βs effect on motors appears specific to kinesin-1. The MAP7 family does not significantly impede or boost dynein (the major minus-end-directed motor) (www.nature.com). Additionally, both MAP7 and Tau were found to inhibit kinesin-3 (another plus-end motor) (www.nature.com), indicating that the interplay of MAP7D2 with motors might depend on motor type and context. But for the canonical axonal transport by kinesin-1, MAP7D2 is a positive facilitator. The net result of MAP7D2βs presence is increased polarized transport: experiments showed that neurons with reduced MAP7D2 had a buildup of vesicles in the soma and a deficit in axonal cargo, while neurons with normal MAP7D2 efficiently traffic vesicles into axons (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This aligns with the observed consequences on axon outgrowth β with proper supply of materials via kinesin, axons grow and develop normally, whereas without MAP7D2-mediated transport, axons suffer shortages and growth defects. In summary, MAP7D2 is crucial for kinesin-1 mediated axonal transport, acting as a microtubule-tethered receptor that catches kinesin motors and boosts their ability to haul cargo into the axon.
By virtue of stabilizing microtubules and promoting axonal transport, MAP7D2 plays several important roles in cell and developmental biology:
Axon Formation and Growth: MAP7D2 is required for normal axon development. When MAP7D2 is knocked down in immature neurons, many cells fail to specify or maintain a proper axon (pmc.ncbi.nlm.nih.gov). Axons that do form are often shorter and less developed. These defects are likely due to impaired delivery of membrane and protein cargos needed for axon extension, as well as less stable microtubule tracks to support elongation. MAP7D2βs localization at the nascent axon (stage 3 neurons) at the moment of polarization (pmc.ncbi.nlm.nih.gov) supports the idea that it helps βtriggerβ or stabilize the newly forming axon. Furthermore, MAP7D2 may influence microtubule arrangement at the axon initial segment, which is known to be crucial for defining axon identity. Its absence could perturb the bundled, uniform microtubule array normally present in the proximal axon, thereby compromising axon integrity.
Neuronal Migration: Developing neurons often migrate along the radially organized glial scaffold or tangential paths to reach their proper cortical layer or brain region. This migration requires coordinated nucleus-centrosome movement and forward translocation of the cell, processes that depend on microtubules and motors. Pan et al. found that MAP7D2 knockdown led to defects in neuronal migration in vivo, indicating neurons were slower or stalled in reaching their destinations (pmc.ncbi.nlm.nih.gov). Likely, the inability to efficiently transport organelles (such as the Golgi or lysosomes) and signaling molecules along the leading process could underlie these migration issues. Additionally, since ensconsin/MAP7 in flies is known to affect nuclear positioning in muscle cells (through kinesin/dynein) (www.nature.com), human MAP7D2 might analogously impact nuclear movement in migrating neurons. Thus, MAP7D2βs influence extends beyond single-cell transport to larger-scale developmental events.
Cell Shape and Motility: Outside the nervous system, MAP7D2βs role in stabilizing microtubules can modulate cell morphology and movement. For instance, the increased random motility observed in MAP7D2-deficient cells (pmc.ncbi.nlm.nih.gov) suggests that normally MAP7D2 helps maintain a stable cell front-back polarity that restrains random migration. Cells lacking MAP7D2, with more dynamic microtubules, may more readily extend random protrusions and change direction. In the testis, Sertoli cells rely on a stable microtubule network for their polarized structure (they transport nutrients to developing germ cells along microtubule tracks). Although not yet empirically shown, MAP7D2 in Sertoli cells may similarly contribute to the stability of microtubules that support these nursing processes.
Redundancy and Compensation: Within the MAP7 family, there may be some overlapping functions. MAP7D1, which is broadly expressed (including in certain cell lines), also binds kinesin-1 and stabilizes microtubules (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In neurons, MAP7D1 is present albeit at lower levels than MAP7D2 (pmc.ncbi.nlm.nih.gov), and MAP7 (ensconsin) is also expressed in many cell types. Knockdown studies indicate that removing any one of MAP7, D1, or D2 can impair kinesin-1 transport, and all three need to be absent to completely abolish kinesin-1 recruitment to microtubules (pmc.ncbi.nlm.nih.gov). This suggests a degree of functional redundancy β if MAP7D2 is missing, MAP7D1 (or MAP7 in some cells) might partially compensate in binding motors. However, the unique localization of MAP7D2 to the AIS in neurons is not substituted by MAP7D1 (which is mainly somatodendritic) (pmc.ncbi.nlm.nih.gov). Thus, for the specific task of axon entry, MAP7D2 is non-redundant and crucial. The specialization of MAP7 family members in different compartments reflects evolutionary tuning: MAP7D2 evolved to fulfill a neuron-specific function at the axon gateway, while others cover duties in other regions or cell types.
As a core component of axonal transport and cytoskeletal stability, MAP7D2 dysfunction could potentially contribute to neurological diseases or other pathologies, though direct links are only beginning to be explored. Given its X-chromosomal location and brain-specific imprinting, MAP7D2 is a genomic element of interest in neurodevelopment β for example, mutations or epigenetic misregulation could hypothetically lead to X-linked brain disorders or contribute to developmental syndromes. However, to date, no Mendelian disorder has been definitively linked to MAP7D2, and it has not emerged as a frequent mutation in neurodevelopmental disorder screens. This may be due in part to redundancy (other MAP7 family members compensating) or because complete loss of MAP7D2 might be embryonic lethal or result in complex phenotypes not yet mapped to this gene.
There is some evidence implicating MAP7D2 in cancer biology. Microtubule-associated proteins are often dysregulated in cancers, as changes in the cytoskeleton can facilitate tumor cell migration and division. A 2021 analysis of non-small cell lung cancer (NSCLC) patient data found that MAP7D2 mRNA is significantly upregulated in tumors compared to normal lung tissue (pmc.ncbi.nlm.nih.gov). In two independent datasets, lung tumors showed approximately 5- to 7-fold higher MAP7D2 expression than normal controls (e.g. a 6.8-fold increase in lung adenocarcinoma samples) (pmc.ncbi.nlm.nih.gov). This was validated by RT-qPCR on patient samples, confirming that MAP7D2 (and MAP7) transcripts are higher in tumor tissue than in adjacent normal tissue for the majority of NSCLC cases (pmc.ncbi.nlm.nih.gov). The biological reason could be that tumor cells benefit from altered microtubule dynamics or transport β for instance, elevated MAP7D2 might stabilize microtubules to assist cancer cell division or enhance organelle transport needed for rapid growth. Interestingly, the same study noted that other MAPs like MAP7D3 and MAP2 were downregulated in lung cancer, suggesting a selective advantage to increasing MAP7/MAP7D2 while decreasing some other MAPs (pmc.ncbi.nlm.nih.gov).
In terms of prognosis, MAP7D2 overexpression alone did not show a strong correlation with patient survival in NSCLC (pmc.ncbi.nlm.nih.gov). KaplanβMeier analyses indicated that high MAP7D2 levels were not significantly associated with overall survival differences (p ~0.96 in TCGA data) (pmc.ncbi.nlm.nih.gov), unlike some MAP family genes where expression did correlate with outcomes. On the other hand, high expression of MAP7 (the original ensconsin) or MAP7D3 was linked to better survival in that study (pmc.ncbi.nlm.nih.gov). These somewhat counterintuitive results underscore that the roles of MAP7-family proteins in cancer are complex and possibly context-dependent. It is plausible that MAP7D2 upregulation aids tumor cell processes like invasion, but also could make cells more reliant on a stable cytoskeleton (which might be a vulnerability under certain treatments). There is interest in understanding whether altering MAP7D2 levels affects cancer cell sensitivity to microtubule-targeting chemotherapies (such as taxanes), though this has not yet been thoroughly investigated.
Beyond cancer, the significance of MAP7D2 is being examined in other contexts. For example, microtubule stability and transport are critical in neurodegenerative diseases (like Alzheimerβs), where Tau pathology causes transport failure. While MAP7D2 has not been directly tied to Alzheimerβs, the principle of MAP competition (Tau vs MAP7 family) raises the question of whether boosting MAP7D2 could ameliorate transport deficits in tau-rich diseased neurons. Additionally, the specific expression of MAP7D2 in olfactory bulb neurons could be relevant for olfactory system function or disorders β defects in axonal transport in olfactory neurons might impair smell, though no reports link MAP7D2 to anosmia yet. Given its testis expression, one might also ask if MAP7D2 is needed for sperm development or male fertility; again, this remains to be studied. Some high-throughput studies have occasionally flagged MAP7D2 in gene lists (for example, as differentially expressed in certain conditions or a potential biomarker in patent filings (patents.google.com) (patents.google.com)), but these need validation.
In summary, MAP7D2βs clinical relevance is still emerging. Its clear importance in neuronal development makes it a candidate gene to screen in unexplained neurodevelopmental disorders, especially with X-linked patterns. Its upregulation in lung cancer suggests it might contribute to tumor cell behavior, or serve as part of a biomarker panel for cancer diagnosis or treatment response (e.g. some have proposed MAP gene expression profiles to predict immunotherapy responsiveness (pmc.ncbi.nlm.nih.gov)). As research continues, MAP7D2 could become a target for modulating axonal regeneration β for instance, enhancing MAP7D2 function might improve axon repair by stabilizing microtubules and facilitating transport in injured neurons. Conversely, in diseases of excess stability or aberrant axon growth, reducing MAP7D2 might be considered. At present, however, no therapies directly target MAP7D2, and its value lies in improving our understanding of the cytoskeletal control of cell polarity and transport.
Research on MAP7D2 and the MAP7 family has accelerated in the past few years (2019β2024), providing new insights into their molecular mechanisms:
Structural Biology Advances (2023β2024): Investigators have begun to resolve how MAP7 proteins interact with microtubules at the atomic level. In 2024, a cryo-electron microscopy study of MAP7 (ensconsin) bound to microtubules visualized the MAP7 microtubule-binding domain attaching along the microtubule surface (www.nature.com). The MAP7 MT-binding helix sits in the groove between protofilaments, explaining how it can stabilize the lattice without displacing tubulin dimers. Such structural knowledge helps interpret MAP7D2βs function, since MAP7D2βs N-terminus is homologous. The structural study also reinforced that MAP7βs binding is unique compared to other MAPs (like Tau), which is why MAP7 can dislodge Tau β it binds with an βinvadingβ mechanism that pushes Tau aside (www.nature.com). Understanding these interactions at high resolution could guide the design of molecules to modulate MAP7D2-MT binding (for research or therapeutic purposes).
Differential Roles of Family Members: Work by Kikuchi et al. (2022) provided a side-by-side comparison of MAP7D2 and MAP7D1, highlighting distinct mechanisms in stabilizing microtubules (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This comparative approach is refining our view of how each MAP7 protein contributes in cells. Another study examined MAP7D1 in human disease: a 2023 report found a mutation in MAP7D1 in a rare syndrome (Shwachman-Diamond syndrome) that affected microtubule stability and cell division, underscoring the significance of MAP7 family proteins in mitotic processes as well (pmc.ncbi.nlm.nih.gov). While MAP7D1βs case may not directly involve MAP7D2, it suggests that the balance of MAP7 proteins is critical in various cell types. We may soon see similar genetic or cell studies testing MAP7D2βs role by creating human MAP7D2 knockout cell lines or even animal models (knockout mice) to observe the phenotypic consequences in vivo.
Expert commentary: Scientists in the field emphasize that MAP7D2 exemplifies a larger principle of spatial regulation of intracellular transport. In a 2018 commentary on MAP7/tau competition, researchers noted that βmotor and non-motor MAPs converge on microtubules, and competition between them dictates motor access, ensuring the proper distribution of transport activityβ (www.nature.com) (www.nature.com). MAP7D2βs localized action in the axon initial segment is a prime example of this principle: it defines where kinesin motors can attach and drive cargo. Dr. Casper Hoogenraad and colleagues (who authored multiple MAP7 studies) have described the concept of local MAP control as an emerging theme (pmc.ncbi.nlm.nih.gov). They argue that cells use specific MAPs like MAP7D2 as βlocal enhancersβ of motor function in subcellular domains, which adds a new layer to how we think about vesicle trafficking regulation beyond the motor proteins themselves (pmc.ncbi.nlm.nih.gov). This expert perspective highlights why MAP7D2 is an exciting protein to study β it is teaching us how cytoskeletal tracks are not passive highways but are actively managed by βtraffic controllersβ (the MAPs) that determine where and when motors can drive cargo.
Ongoing and future directions: Current research is likely to delve deeper into MAP7D2βs role in neurons in vivo. For instance, it will be important to see if Map7d2 knockout mice have neurodevelopmental phenotypes (such as brain wiring defects or behavioral abnormalities), which would mirror the cellular findings. Researchers are also investigating whether MAP7D2 function changes in mature neurons versus developing neurons β for example, does it continue to assist transport in adult neurons, and what happens to axon maintenance if MAP7D2 is lost later in life? Another emerging question is how MAP7D2 itself is regulated. Some evidence suggests MAP7D2 might be a substrate of post-translational modifications (the iPTMnet database indicates potential phosphorylation sites (research.bioinformatics.udel.edu)), which could modulate its binding affinity to microtubules or kinesin. Additionally, since MAP7D2 is enriched at the AIS, it may interact with the master organizer of the AIS (ankyrin-G) or other AIS-enriched proteins; exploring these interactions could reveal how MAP7D2 is anchored in that compartment (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Finally, from a biomedical standpoint, there is growing interest in whether modulating MAP7D2 can influence nerve regeneration or degeneration. Enhancing microtubule stability and transport is generally beneficial for axon regeneration after injury, so MAP7D2 or its pathways might become targets to bolster regeneration. Conversely, in scenarios like cancer metastasis, inhibiting a MAP that stabilizes microtubules might reduce cancer cell invasiveness. These translational angles remain speculative but illustrate the potential real-world applications stemming from MAP7D2 research.
In conclusion, MAP7D2 is a specialized microtubule-associated protein that anchors and activates kinesin-1 motors in neuronal axons, thereby ensuring efficient cargo delivery and stable axon development. It reinforces microtubule tracks through direct binding, modulates cell motility, and creates a permissive environment for axonal transport. Recent advances from 2019β2024 have solidified our understanding of its molecular function and unique localization, and they emphasize a broader principle of microtubule track regulation by MAP βgatekeepers.β As one recent study succinctly stated, MAP7 family members like MAP7D2 are crucial in recruiting kinesin-1 to microtubules and activating it (pmc.ncbi.nlm.nih.gov) β a finding that reshapes how we view intracellular transport regulation. Ongoing research into MAP7D2 will further clarify its roles in physiology and disease, potentially uncovering new strategies to manipulate the cytoskeleton for therapeutic benefit.
id: Q96T17
gene_symbol: MAP7D2
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
MAP7D2 is a microtubule-associated protein of the MAP7/ensconsin family that localizes
to the proximal axon and serves as a critical cofactor for kinesin-1-mediated cargo
transport. The protein directly binds microtubules via its N-terminal region and
interacts with kinesin-1 family members (KIF5A/B/C) through its C-terminus. MAP7D2
functions to recruit and activate kinesin-1 on microtubules at the proximal axon/axon
initial segment, thereby gating anterograde transport of organelles (mitochondria,
lysosomes, ER-derived vesicles) into the axon. It stabilizes microtubules through
direct binding and plays roles in controlling cell motility and neurite outgrowth.
The protein also localizes to centrosomes, midbody during cytokinesis, and neuron
projections. Recent GWAS studies have implicated MAP7D2 in age-related hearing loss,
consistent with its expression in inner ear hair cells.
existing_annotations:
- term:
id: GO:0000226
label: microtubule cytoskeleton organization
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation based on phylogenetic inference from MAP7 family members. MAP7D2
belongs to the MAP7 family which includes MAP7, MAP7D1, MAP7D2, and MAP7D3,
all of which regulate microtubule organization. Pan et al. 2019 demonstrated
that MAP7D2 localizes to microtubules and regulates their organization at the
proximal axon. Kikuchi et al. 2022 showed MAP7D2 stabilizes microtubules through
direct binding [file:human/MAP7D2/MAP7D2-deep-research-falcon.md].
action: ACCEPT
reason: >-
This annotation is well-supported by both phylogenetic evidence and direct
experimental studies. MAP7D2 clearly functions in microtubule cytoskeleton
organization as a core function, recruiting kinesin-1 to microtubules and
stabilizing them.
supported_by:
- reference_id: PMID:30784582
supporting_text: "MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-Mediated Cargo Transport into the Axon"
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2 and MAP7D1 facilitate microtubule stabilization through distinct mechanisms in neuronal cells"
- term:
id: GO:0015630
label: microtubule cytoskeleton
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for cellular component. MAP7D2 is active in the microtubule
cytoskeleton, binding directly to microtubules and recruiting kinesin-1 motor
proteins. This is the primary site of MAP7D2 function.
action: ACCEPT
reason: >-
This cellular component annotation accurately reflects where MAP7D2 functions.
The protein binds microtubules via its N-terminal domain and this is its primary
site of activity.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2's N-terminus binds microtubules; its C-terminus underlies kinesin-1 interaction"
- term:
id: GO:0000226
label: microtubule cytoskeleton organization
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation from combined automated methods, consistent with ortholog
annotations and InterPro domain predictions. This duplicates the IBA annotation
with different evidence.
action: ACCEPT
reason: >-
While this duplicates the IBA annotation, the IEA annotation correctly captures
the same function from automated pipelines. The annotation is accurate.
supported_by:
- reference_id: PMID:30784582
supporting_text: "MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-Mediated Cargo Transport into the Axon"
- term:
id: GO:0005813
label: centrosome
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation based on ortholog data. Kikuchi et al. 2022 showed that MAP7D2
is prominent at centrosomes in neuronal cell lines. UniProt also notes centrosomal
localization based on similarity evidence.
action: ACCEPT
reason: >-
Centrosome localization is supported by experimental data from mouse orthologs
and is consistent with MAP7D2's role as a microtubule-associated protein.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2 is prominent at centrosomes and partially along microtubules"
- term:
id: GO:0005856
label: cytoskeleton
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
IEA annotation from UniProtKB subcellular location mapping. This is a broader
term than GO:0015630 (microtubule cytoskeleton).
action: ACCEPT
reason: >-
While this is a more general term than the microtubule cytoskeleton annotation,
it is not incorrect. MAP7D2 is indeed a cytoskeleton-associated protein. The
more specific microtubule cytoskeleton annotation provides better granularity.
supported_by:
- reference_id: UniProt:Q96T17
supporting_text: "Cytoplasm, cytoskeleton"
- term:
id: GO:0015630
label: microtubule cytoskeleton
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation from combined automated methods, duplicating the IBA annotation.
Well-supported by ortholog data.
action: ACCEPT
reason: >-
Accurate annotation consistent with the IBA evidence. MAP7D2 functions at
the microtubule cytoskeleton.
supported_by:
- reference_id: PMID:30784582
supporting_text: "MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-Mediated Cargo Transport into the Axon"
- term:
id: GO:0030424
label: axon
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation based on ortholog data. This is strongly supported by experimental
evidence. Pan et al. 2019 demonstrated that MAP7D2 accumulates at the proximal
axon in hippocampal neurons, and this localization is critical for its function
in gating kinesin-1-mediated transport.
action: ACCEPT
reason: >-
Axon localization is a core aspect of MAP7D2 function and is directly supported
by published experimental evidence from PMID:30784582 (Pan et al. 2019).
supported_by:
- reference_id: PMID:30784582
supporting_text: "MAP7D2-N) accumulates at the proximal axon"
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2 localizes to the proximal axon and locally promotes kinesin-1-mediated cargo transport into the axon"
- term:
id: GO:0030496
label: midbody
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation based on ortholog data. Kikuchi et al. 2022 showed MAP7D2
accumulates at the midbody during cytokinesis. UniProt confirms this localization
by similarity.
action: KEEP_AS_NON_CORE
reason: >-
Midbody localization during cytokinesis is a secondary aspect of MAP7D2
function, not its core role in axonal transport. The annotation is accurate
but represents a non-core function.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "accumulates at the midbody during cytokinesis"
- term:
id: GO:0043005
label: neuron projection
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation based on ortholog data. MAP7D2 localizes to neuron projections,
particularly the axon. This is consistent with its primary role in neurons.
action: ACCEPT
reason: >-
Neuron projection localization is accurate and represents a core aspect of
MAP7D2 function in neuronal cells.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2 concentrates at the proximal axon (overlapping the AIS region) in developing hippocampal neurons"
- term:
id: GO:0005874
label: microtubule
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara ortholog transfer. MAP7D2 directly binds
microtubules via its N-terminal domain. Kikuchi et al. 2022 determined binding
affinity (KD ~6x10^-7 M).
action: ACCEPT
reason: >-
Microtubule localization is fundamental to MAP7D2 function. The protein directly
binds microtubules as demonstrated biochemically.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "Microtubule co-sedimentation determined an apparent KD on the order of ~6x10^-7 M"
- term:
id: GO:0008017
label: microtubule binding
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation from combined automated methods. Microtubule binding is a core
molecular function of MAP7D2, mediated by the N-terminal region.
action: ACCEPT
reason: >-
This is a core molecular function of MAP7D2. The protein binds microtubules
directly and this binding is essential for its function in kinesin-1 recruitment.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2 directly binds microtubules via its N-terminal half"
- term:
id: GO:0019894
label: kinesin binding
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation from combined automated methods. MAP7D2 interacts with kinesin-1
family members (KIF5A, KIF5B, KIF5C) through its C-terminal domain. This
interaction is critical for promoting kinesin-1-mediated axonal transport.
action: ACCEPT
reason: >-
Kinesin binding is a core molecular function of MAP7D2. The protein serves
as a cofactor that recruits and activates kinesin-1 on microtubules.
supported_by:
- reference_id: PMID:30784582
supporting_text: "Kinesin-1-Mediated Cargo Transport into the Axon"
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7 family proteins regulate kinesin-1 recruitment and activation"
- term:
id: GO:0061564
label: axon development
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. MAP7D2 contributes to axon development
by facilitating polarized entry of cargoes into axons, supporting axon formation
and branching.
action: ACCEPT
reason: >-
Axon development is a core biological process for MAP7D2. The protein's role
in kinesin-1-mediated cargo transport at the proximal axon directly contributes
to axon development and neuronal polarity.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2 facilitates polarized entry of cargoes (mitochondria, lysosomes, ER-derived organelles) into axons, thereby contributing to axon formation, branching, and neuronal migration"
- term:
id: GO:0140778
label: microtubule stabilizing activity
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation from Ensembl Compara. MAP7D2 stabilizes microtubules through
direct binding. Kikuchi et al. 2022 showed that MAP7D2 loss reduces nocodazole
resistance (indicating reduced MT stability).
action: ACCEPT
reason: >-
Microtubule stabilizing activity is a core molecular function of MAP7D2. This
has been directly demonstrated experimentally.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2 directly binds microtubules via its N-terminal half and stabilizes microtubules"
- term:
id: GO:0000226
label: microtubule cytoskeleton organization
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation based on sequence similarity to rat ortholog (D4A4L4). This
duplicates the IBA annotation with different evidence type.
action: ACCEPT
reason: >-
The annotation accurately captures MAP7D2's role in microtubule cytoskeleton
organization. ISS evidence from well-characterized orthologs is reliable.
supported_by:
- reference_id: PMID:30784582
supporting_text: "MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-Mediated Cargo Transport into the Axon"
- term:
id: GO:0008017
label: microtubule binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation based on sequence similarity. Duplicates the IEA annotation.
Microtubule binding is well-established for MAP7D2.
action: ACCEPT
reason: >-
Core molecular function accurately captured. The ISS evidence provides additional
confidence from ortholog studies.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2's N-terminus binds microtubules"
- term:
id: GO:0019894
label: kinesin binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation based on sequence similarity. Duplicates the IEA annotation.
Kinesin binding is a core function of MAP7D2.
action: ACCEPT
reason: >-
Core molecular function. MAP7D2 binding to kinesin-1 family members is essential
for its biological role.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2 interacts with kinesin-1 family members (KIF5A/B/C)"
- term:
id: GO:0061564
label: axon development
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation based on sequence similarity. Duplicates the IEA annotation.
Axon development is a core process for MAP7D2.
action: ACCEPT
reason: >-
Core biological process. MAP7D2's role in axon development through kinesin-1
recruitment is well-documented.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "contributing to axon formation, branching, and neuronal migration"
- term:
id: GO:0005813
label: centrosome
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation based on sequence similarity to mouse ortholog (A2AG50).
Duplicates the IEA annotation. Centrosome localization is documented.
action: ACCEPT
reason: >-
Accurate cellular localization supported by ortholog studies. Centrosome
localization is consistent with MAP7D2's role in microtubule organization.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2 is prominent at centrosomes"
- term:
id: GO:0005874
label: microtubule
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation based on sequence similarity. Duplicates the IEA annotation.
MAP7D2 localizes to microtubules via direct binding.
action: ACCEPT
reason: >-
Core cellular localization. MAP7D2 directly binds and localizes to microtubules.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2 directly binds microtubules via its N-terminal half"
- term:
id: GO:0030496
label: midbody
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation based on sequence similarity. Duplicates the IEA annotation.
Midbody localization during cytokinesis is documented.
action: KEEP_AS_NON_CORE
reason: >-
Accurate localization but represents a non-core function. Midbody accumulation
during cytokinesis is secondary to MAP7D2's primary role in axonal transport.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "accumulates at the midbody during cytokinesis"
- term:
id: GO:0043005
label: neuron projection
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation based on sequence similarity. Duplicates the IEA annotation.
MAP7D2 localizes to neuron projections, especially axons.
action: ACCEPT
reason: >-
Core cellular localization for MAP7D2's function in neurons.
supported_by:
- reference_id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
supporting_text: "MAP7D2 concentrates at the proximal axon (overlapping the AIS region) in developing hippocampal neurons"
references:
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings:
- statement: Used for ISS annotations transferred from rat and mouse orthologs
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings:
- statement: Used for IBA annotations from MAP7 family phylogenetic analysis
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings:
- statement: Used for cytoskeleton localization annotation
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings:
- statement: Used for IEA annotations from Ensembl ortholog comparisons
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings:
- statement: Used for combined IEA annotations from multiple automated pipelines
- id: PMID:30784582
title: MAP7D2 Localizes to the Proximal Axon and Locally Promotes Kinesin-1-Mediated
Cargo Transport into the Axon
findings:
- statement: MAP7D2 accumulates at the proximal part of the axon
supporting_text: "MAP7D2-N) accumulates at the proximal axon"
- statement: MAP7D2 promotes kinesin-1-mediated cargo transport into axons
supporting_text: "Kinesin-1-Mediated Cargo Transport into the Axon"
- statement: Depletion of MAP7D2 reduces axonal entry of organelle cargos
supporting_text: "Locally Promotes Kinesin-1-Mediated Cargo Transport into the Axon"
- id: file:human/MAP7D2/MAP7D2-deep-research-falcon.md
title: Deep research summary for MAP7D2 gene function
findings:
- statement: MAP7D2's N-terminus binds microtubules; C-terminus interacts with kinesin-1
- statement: MAP7D2 concentrates at the proximal axon/AIS in hippocampal neurons
- statement: MAP7D2 recruits/activates kinesin-1 to promote cargo transport
- statement: MAP7D2 directly binds microtubules via N-terminal half
- statement: MAP7D2 stabilizes microtubules (loss reduces nocodazole resistance)
- statement: MAP7D2 localizes to centrosomes and midbody during cytokinesis
- statement: Binding affinity KD ~6x10^-7 M for microtubules
- statement: MAP7 proteins act as microtubule-tethered kinesin-1 activators
- statement: MAP7 family promotes kinesin-1 landing and increases processivity
- statement: MAP7D2 significantly associated with age-related hearing loss
- statement: MAP7D2 expressed in mouse and human inner ear tissues
- id: file:human/MAP7D2/MAP7D2-deep-research-cyberian.md
title: Cyberian deep research on MAP7D2 function
findings: []
core_functions:
- molecular_function:
id: GO:0008017
label: microtubule binding
description: >-
MAP7D2 directly binds microtubules via its N-terminal region with an affinity
of KD ~6x10^-7 M. This binding is fundamental to its function as a microtubule-associated
protein and is required for its role in kinesin-1 recruitment.
locations:
- id: GO:0030424
label: axon
directly_involved_in:
- id: GO:0000226
label: microtubule cytoskeleton organization
- molecular_function:
id: GO:0019894
label: kinesin binding
description: >-
MAP7D2 interacts with kinesin-1 family members (KIF5A/B/C) through its C-terminal
domain. This interaction is essential for recruiting kinesin-1 to microtubules
at the proximal axon and promoting kinesin-1-mediated cargo transport.
locations:
- id: GO:0015630
label: microtubule cytoskeleton
directly_involved_in:
- id: GO:0061564
label: axon development
- molecular_function:
id: GO:0140778
label: microtubule stabilizing activity
description: >-
MAP7D2 stabilizes microtubules through direct binding. Loss of MAP7D2 reduces
microtubule stability as measured by nocodazole resistance assays.
locations:
- id: GO:0005874
label: microtubule
suggested_questions:
- question: >-
Does MAP7D2 have specific roles in inner ear hair cells beyond general kinesin-1
recruitment, given the GWAS association with hearing loss?
- question: >-
What is the relationship between MAP7D2 and other MAP7 family members in regulating
axonal transport - are they redundant or do they have distinct cargo specificities?
- question: >-
Does MAP7D2 play a role in non-neuronal cell types, given its expression in brain
and epididymis?
suggested_experiments:
- description: Conditional knockout of MAP7D2 in mouse inner ear to validate hearing loss phenotype
hypothesis: Loss of MAP7D2 in inner ear cells leads to hearing impairment due to disrupted intracellular transport
- description: Live imaging of cargo transport in neurons with MAP7D2 depletion to determine cargo specificity
hypothesis: MAP7D2 has cargo-specific roles in axonal transport distinct from other MAP7 family members
- description: Structure determination of MAP7D2-microtubule and MAP7D2-kinesin-1 complexes to understand molecular mechanism
hypothesis: MAP7D2 binds simultaneously to microtubules and kinesin-1 to facilitate motor protein recruitment